The Problem The Search for Biomarkers in Bipolar Disorder

Loginova L.V., Smirnova L.P., Seregin A.A., Dmitrieva E.M., Mazin E.V., Simutkin G.G.

Federal State Organization «Research Institute of Mental Health», Siberian Branch of the Russian Academy of Medical Sciences; State educational institution of higher professional education «Siberian State Medical University, Tomsk», Russian Federation

Abstract: The paper presents the results of a comparative analysis of blood serum protein bipolar disorder patients and healthy individuals. When analyzing the differences of serum protein composition in patients with bipolar disorder identified two proteins that are not found in healthy individuals: Ankyrin repeat domain-containing protein 12; Glutamate [NMDA]-receptor subunit zeta-1
Keywords: bipolar disorder, proteomics, biomarkers

REFERENCES
1. Maj M., Akiskal H. S., Lopez-Ibor J. J., Sartorius N. Bipolar Disorder. WPA Series Evidence and Experience in Psychiatry. — 2002. — V. 5. 9
2. Dunner D.L., Fleiss J.L., Fieve R.R. The course of development of mania in patients with recurrent depression. Amer. J. Psychiatry. — 1976. — V. 133. — P. 905—908.
3. Schastnyy E. D., Simutkin G. G., Nevidimova T. I., Lebedeva E. V., Popova N. M., Shakhurova N. I., Rozin A. I. Clinical-pathogenrtic, socio-epidemiological factors of ontogenesis of affective disorders (aspects of early diagnosis and prevention). Siberian Herald of psychiatry and addiction psychiatry, 2011. – 4 (67). – p. 23–33.
4. Ivanova, S. A., Phedorenko O.Yu, Smirnova L.P. Semke A.V. The search for biomarkers and the development of pharmacogenetic approaches to personalized treatment of patients with schizophrenia. Siberian Herald of psychiatry and addiction psychiatry, 2013, No.1(76), P.12-18.
5. Loginova L.V., Smirnova L.P., Koval V.V. et al. Mass-spectromertric analysis of serum proteins in patients with schizophrenia. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences, 2011, Vol.31, No6, pp.63–68.
6. Lakhan, S E Schizophrenia proteomics: biomarkers on the path to laboratory medicine? / S E Lakhan. Diagnostic Pathology. – 2006, №27, S.11-13.
7. Wyllie D.J.A., Livesey M.R., and Hardingham G.E. et al. Influence of GluN2 subunit identity on NMDA receptor function. Neuropharmacology. – 2013. – Vol. 74. – P. 4–17
8. Ivanova S.A., Loonen A.J. M., Pechlivanoglou P. et al. NMDA receptor genotypes associated with the vulnerability to develop dyskinesia. Translational Psychiatry. – 2012. – №2 (e67).
9. Fountoulakis, K. N. The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder. Curr Pharm Des. – 2012. – Vol. 18. – P. 1605- 1608.

Authors
Loginova Larisa V.
Federal State Organization «Research Institute of Mental Health», Siberian Branch of the Russian Academy of Medical Sciences,
Russian Federation, Tomsk 634014, g.Tomsk, ul.Aleutskaja,4

Smirnova Ljudmila P.
Mental Health Research Institute SB RAMSci, candidate of medical sciences, senior researcher of the laboratory of molecular genetics and biochemistry

Seregin Alexandr A., e-mail: apocalips1991@mail.ru
Siberian State Medical University, SSMU, student,
Russian Federation, 634050, Tomsk, Moskovskij trakt, 2
Mental Health Research Institute SB RAMSci, technician of the laboratory of molecular genetics and biochemistry

Dmitrieva Elena M.
Siberian State Medical University, SSMU, student
Mental Health Research Institute SB RAMSci, technician of the laboratory of molecular genetics and biochemistry

Mazin Evgenij V.
Siberian State Medical University, SSMU, student

Simutkin German G.
Federal State Organization «Research Institute of Mental Health», Siberian Branch of the Russian Academy of Medical Sciences, Russia, Tomsk

 
 
 

Authorization